Exonate Becomes Foventa Therapeutics

The new name, which takes inspiration from the fovea, marks the company's transition to focus on clinical development in non-proliferative diabetic retinopathy. In earlier clinical trials, FOV407 exhibited remarkable ability to suppress harmful vascular leakage in patients' eyes....